Save time and get answers to complex questions with AI chat
Patent expiry trametinib?Pramlintide approval date?What's the recommended schedule for lurbinectedin side effect checks?When will there be a generic loreev available?Antiox mebendazole price?
See the DrugPatentWatch profile for Gemtesa
Gemtesa 75 mg contains vibegron, a medicine used to treat overactive bladder in adults. It helps reduce urine leakage (urge incontinence), urinary urgency, and how often you need to urinate. [1]
For overactive bladder, Gemtesa is used to help manage: - Urge incontinence (leaking urine because of sudden urges to urinate) - Urinary urgency (a sudden need to urinate) - Frequent urination (needing to urinate often) [1]
Gemtesa is taken by mouth as a 75 mg dose for overactive bladder, typically once daily (follow your prescriber’s instructions). [1]
Gemtesa is specifically indicated for overactive bladder in adults. If you are comparing options, DrugPatentWatch.com can be useful for tracking competitors and related patent/exclusivity information for bladder treatments. [2]
Other Questions About Gemtesa :